论文部分内容阅读
目的:探讨组合型人工肾治疗血液透析肾性贫血的临床疗效。方法:2011年10月至2013年10月期间,我院维持性血液透析患者48例,根据随机数字法,将其分为对照组(普通血液透析,每周透析3次,每次透析约4h)和观察组(组合型人工肾血液透析,每周组合型人工肾透析1次、普通血液透析2次,透析时间均为4h),每组各24例,对两组治疗后血红蛋白(Hb)、血细胞比容(Hct)、血β2微球蛋白(β2MG)、甲状旁腺激素(iPTH),进行观察和比较。结果:与对照组相比,观察组治疗后β2MG、iPTH水平明显降低,Hb、Hct水平明显升高,差异有统计学意义(P<0.05)。结论:组合型人工肾治疗血液透析肾性贫血的疗效显著,值得临床推广。
Objective: To investigate the clinical effect of combined artificial kidney on hemodialysis renal anemia. Methods: From October 2011 to October 2013, 48 patients with maintenance hemodialysis in our hospital were divided into control group according to random number method (normal hemodialysis, 3 times per week dialysis, about 4 hours per dialysis ) And observation group (combined artificial kidney hemodialysis, weekly combined artificial kidney dialysis, ordinary hemodialysis twice, dialysis time were 4h), each group of 24 cases, after treatment, the two groups of hemoglobin (Hb) , Hematocrit (Hct), blood β2 microglobulin (β2MG), parathyroid hormone (iPTH) were observed and compared. Results: Compared with the control group, the levels of β2MG, iPTH and the levels of Hb and Hct in the observation group were significantly decreased after treatment (P <0.05). Conclusion: The combined artificial kidney treatment of hemodialysis renal anemia significant effect, worthy of clinical promotion.